A hypothesis is formulated about the mechanisms causing adverse reactions to contrast media. Contrast media act in two ways. They stimulate the mast cells to release histamine and leukotrienes, and they inhibit the enzymes which otherwise degrade leukotrienes. Thus individuals, especially those with a history of allergy, are easily exposed to undue amounts of leukotrienes and these are responsible for the adverse reactions.
AnsellG.: Adverse reactions to contrast agents. Scope of problem. Invest. Radiol.5 (1970), 374.
2.
BachM. K.: Inhibitors of leukotriene synthesis and action. In: The leukotrienes. Chemistry and biology, p. 163. Edited by ChakrinL. W.Bailey.D. M.Academic Press, Orlando, Florida1984.
3.
BisgaardH.KristensenJ.SøndergaardJ.: The effect of leucotriene C4 and D4 on cutaneous blood flow in humans. Prostaglandins23 (1982), 797.
4.
BjörkJ.DahlénS.-E.HedqvistP.ArforsK.-E.: Leukotrienes B4 and C4 have distinct microcirculatory actions in vivo. In: Advances in prostaglandin, thromboxane and leukotriene research. Vol. 12, p. 1. Edited by SamuelssonB.PaolittiR.Ramwell.P.Raven Press, New York, 1983.
BraschR. C.CaldwellJ. L.: The allergic theory of radiocontrast agent toxicity. Demonstration of antibody activity in sera of patients suffering major radiocontrast agent reactions. Invest. Radiol.11 (1976), 347.
7.
BurkaJ. F.FlowerR. J.: Effects of modulators of arachidonic acid metabolism on the synthesis and release of slow-reacting substance of anaphylaxis. Brit. J. Pharmacol.65 (1979), 35.
8.
CampR. D. R.CouttsA. A.GreavesM. W.KayA. B.WalportM. J.: Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. J. Invest. Dermatol.78 (1982), 329.
9.
DahlR.: The eosinophil cell and eosinophil cationic protein in bronchial asthma. In: The mast cell, p. 101. Edited by PepysJ.Edwards.A. M.Pitman Medical, Tunbridge Wells, Kent1979.
10.
DahlénS.-E.HedqvistP.HammarströmS.SamuelssonB.: Leukotrienes are potent constrictors of human bronchi. Nature288 (1980), 484.
11.
DrazenJ. M.LewisR. A., Austen K. F. and coll.: Contractile activities of structural analogs of leukotrienes C. and D. Necessity of a hydrophobic region. Proc. Natl. Acad. Sci. USA78 (1981), 3195.
12.
DunnC. R.LasserE. C.SellS.LangJ.: Failure to induce hypersensitivity reactions to opaque contrast media analogs in guinea pigs. Invest. Radiol.10 (1975), 317.
13.
DyerbergJ.BangH. O.: Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. LancetII (1979), 433.
14.
FarrR. S.: The need to re-evaluate acetylsalicylic acid (aspirin). J. Allergy45 (1970), 321.
15.
GiraldoB.BlumenthalM. N.SpinkW. W.: Aspirin intolerance and asthma. A clinical and immunological study. Ann. Intern. Med.71 (1969), 479.
16.
GoetzlE. J.: The conversion of leukotriene C4 to isomers of leukotriene B4 by human eosinophil peroxidase. Biochem. Biophys. Res. Comm.106 (1982), 270.
17.
GorevicP.KaplanA. P.: Contrast agents and anaphylactic-like reactions. J. Allergy Clin. Immunol.63 (1979), 225.
18.
HammarströmS.BernströmK.ÖrningL.DahlénS.-E.HedqvistP.: Rapid in vivo metabolism of leukotriene C3 in the monkey Macaca irus. Biochem. Biophys. Res. Comm.101 (1981), 1109.
19.
HammarströmS.OliwE.FredholmB.: Läkemedelsöverkänslighet – samband med leukotriener? (In Swedish.)Läkartidningen81 (1984), 749.
20.
Hirschberg: Mitteilung über einen Fall von Nebenwirkung des Aspirin. Dtsch. Med. Wschr.28 (1902), 416.
21.
HorstersH.: Anaphylaktisches Zustandbild nach Injektion von mono-jodmethan-sulfosaurem Natrium (Abrodil). Med. Klin.27 (1931), 203.
22.
JakschikB. A.FalkenheinS.ParkerC. W.: Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Proc. Natl. Acad. Sci.74 (1977), 4577.
23.
JuhlinL.MichaëlssonG.ZetterströmO.: Urticaria and asthma induced by food-and-drug additives in patients with aspirin hypersensitivity. J. Allergy Clin. Immunol.50 (1972), 92.
24.
KaplowitzN.KuhlenkampJ.CliftonG.: Hepatic glutathione S-transferases. Identification by gel filtration and in vitro inhibition by organic anions (38779). Proc. Soc. Exp. Biol. Med.149 (1975), 234.
25.
LangE. K.: Clinical evaluation of side effects of radiopaque contrast media administered via intravenous and intraarterial routes in the same patients. A preliminary report. Radiology85 (1965), 665.
26.
LasserE. C.: Basic mechanisms of contrast media reactions. Theoretical and experimental considerations. Radiology91 (1968), 63.
27.
LasserE. C.: Etiology of anaphylactoid responses. The promise of non-ionics. Invest. Radiol. (1985) Suppl. No. 20, p. 79.
28.
LasserE. C.LangJ. H.: Inhibition of acetylcholinesterase by some organic contrast media. A preliminary communication. Invest. Radiol.1 (1966), 237.
29.
LasserE. C.LangJ. H.: Physiologic significance of contrast—protein interactions. I. Study in vitro of some enzyme effects. Invest. Radiol.5 (1970), 514.
30.
LasserE. C.LangJ. H.Curd J. G. and coll.: The plasma contact system in atopic asthma. J. Allergy clin. Immunol.72 (1983), 83.
31.
LasserE. C.LangJ. H.SovakM.KolbW.LyonS.HamlinA. E.: Steroids. Theoretical and experimental basis for utilization in prevention of contrast media reactions. Radiology125 (1977), 1.
32.
LasserE. C.WaltersA. J.LangJ. H.: An experimental basis for histamine release in contrast material reactions. Radiology110 (1974), 49.
33.
LeeC. W.LewisR. A.AustenK. F.CoreyE. J.: Metabolism of leukotriene D (LTD) by human polymorphonuclear leukocytes (PMNs). Fed. Proc.41 (1982), 487a.
34.
LewisR. A.: The role of slow-reacting substance of anaphylaxis (SRS-A) in the inflammatory process. In: The mast cell, p. 97. Edited by PepysJ.Edwards.A. M.Pitman Medical, Tunbridge Wells, Kent1979.
35.
LewisR. A.AustenK. F.: Non-respiratory functions of pulmonary cells. The mast cell. Fed. Proc.36 (1977), 2676.
36.
LichtensteinL. M.ForemanJ. C.ConroyM. C.MaroneG.NewballH. H.: Differences between histamine release from rat mast cells and human basophils and mast cells. In: The mast cell, p. 83. Edited by PepysJ.Edwards.A. M.Pitman Medical, Tunbridge Wells, Kent1979.
37.
LittnerM. R.RosenfieldA. T.UlrichS.PutmanC. E.: Evaluation of bronchospasm during excretory urography. Radiology124 (1977), 17.
38.
MallenM. S.Treatment of intractable asthma with diethylcarbamazine citrate. Ann. Allergy23 (1965), 534.
39.
MannM. R.: The pharmacology of contrast media. Proc. R. Soc. Med.54 (1961), 473.
40.
MichaëlssonG.PetterssonL.JuhlinL.: Purpura caused by food and drug additives. Arch. Dermatol.109 (1974), 49.
41.
MillerW. L.DoppmanJ. L.KaplanA. P.: Renal arteriography following systemic reaction to contrast material. J. Allergy Clin. Immunol.56 (1975), 291.
42.
OlssonO.: Antihistaminic drugs for inhibiting untoward reactions to injections of contrast medium. Acta radiol.35 (1951), 65.
43.
OrangeR. P.AustenW. G.AustenK. F.: Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′5′-adenosine monophosphate. J. Exp. Med.134 (1971), 136(S).
44.
OrangeR. P.MurphyR. C.AustenK. F.: Inactivation of slow-reacting substance of anaphylaxis (SRS-A) by arylsulfatase. J. Immunol.113 (1974), 316.
45.
OvertonE.: Studien über die Narkose, zugleich ein Beitrag zur allgemeinen Pharmakologie. G. Fischer, Jena1901.
46.
PattisonN. R.: Cholic acid binding by anionic glutathione-S-transferase from human liver cytosol. Biochem. Biophys. Res. Commun.102 (1981), 403.
47.
PiperP. J.: Biological actions of the leukotrienes. In: The leukotrienes. Chemistry and biology, p. 215. Edited by ChakrinL. W.Bailey.D. M.Academic Press, Orlando, Florida1984.
48.
RingJ.ArroyaveC. M.FrizlerM. J.TanE. M.: In vitro histamine and serotonine release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells. Clin. Exp. Immunol.32 (1978), 105.
49.
RockoffS. D.AkerU. T.: Contrast media as histamine liberators. VI. Arterial plasma histamine and hemodynamic responses following angiocardiography in man with 75% Hypaque. Invest. Radiol.7 (1972), 403.
50.
RockoffS. D.KuhnC.ChraplyvyM.: Contrast media as histamine liberators. V. Comparison of in vitro mast cell histamine release by sodium and methylglucamine salts. Invest. Radiol.7 (1972), 177.
51.
RosA. M.JuhlinL.MichaëlssonG.: A follow-up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes. Brit. J. Dermatol.95 (1976), 19.
52.
SamterM.BeersR. F.: Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann. Intern. Med.68 (1968), 975.
53.
SamuelssonB.HammarströmS.MurphyR. C.BorgeatP.: Leukotrienes and slow reacting substance of anaphylaxis (SRS-A). Allergy35 (1980), 375.
54.
SandströmC.: Secondary reactions from contrast media and the allergy concept. Acta radiol.44 (1955), 233.
55.
SeidelG.GroppeG.Meyer-BergdorffC.: Contrast media as histamine liberators in man. Agents Actions4 (1974), 143.
56.
ShehadiW. H.: Adverse reactions to intravascularly administered contrast media. Amer. J. Roentgenol.124 (1975), 145.
57.
SiegleR. L.LiebermanP.: Measurement of histamine, complement compounds and immune complexes during patient reactions to iodinated contrast material. Invest. Radiol.11 (1976), 98.
58.
SimonR. A.SchatzM., Stevenson D. D. and coll.: Radiographic contrast media infusions. Measurement of histamine, complement and fibrin split products and correlation with clinical parameters. J. Allergy Clin. Immunol.63 (1979), 281.
59.
SmedegårdG.HedqvistP.DahlénS.-E.RevenäsB.HammarströmS.SamuelssonB.: Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey. Nature295 (1982), 327.
60.
StensonW. F.LobosE.: Sulfasalazine inhibits the synthesis of chemotactic lipids by netrophils. J. Clin. Invest.69 (1982), 494.
61.
SullivanT. J.ParkerC. W.: Pharmacologic modulation of inflammatory mediator release by rat mast cells. Amer. J. Pathol.85 (1976), 437.
62.
TheanderG.: Side-effects of Biligrafin. Acta radiol.43 (1955), 369.
63.
TuengerthalS.: Messung des Atemwiderstandes als Parameter einer Röntgenkontrastmittelnebenwirkung (Vergleich zweier Kontrastmittellösungen). In: Zukunft der Angiographic – Schmerzfreiheit?, p. 73. Symposium, Frankfurt/Main 1979. Byk Gulden Pharmazeutika, Konstanz 1980.
64.
TurnbullL. S.TurnbullL. W.LeitchA. G.CroftonJ. W.KayA. B.: Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma. LancetII (1977), 526.
65.
WalkerJ. L.: The regulatory function of prostaglandins in the release of histamine and SRS-A from passively sensitized human lung tissue. Adv. Biosci.9 (1973), 235.
66.
WassermanS. I.: The mast cell and the inflammatory response. In: The mast cell, preface. Edited by PepysJ.Edwards.A. M.Pitman Medical, Tunbridge Wells, Kent1979.
67.
WassermanS. I.AustenK. F.: Identification and characterization of arylsulfatase A and B of the rat basophil leukemia tumor. J. Biol. Chem.252 (1977), 7074.
68.
WeissJ. W.DrazenJ. M., Coles N. and coll.: Bronchoconstrictor effects of leukotriene C in humans. Science216 (1982), 196.
69.
WeissJ. W.DrazenJ. M., McFadden E. R. and coll.: Airway constriction in normal humans produced by inhalation of leukotriene D. Patency, time course and effect of aspirin therapy. J. Amer. med. Ass.249 (1983), 2814.
